v.klausen
TL3 Regular · Tampere, FI
Reads the primary literature and posts summaries with page numbers. Prefers being corrected to being agreed with.
Joined 15 November 2024 · last posted 7d · groups: newcomer-guides
148 posts, newest first. Showing up to 150.
-
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #47 · Documentation › Doc review · 21 Jul 2026 · 6 likes Promoted topic withdrawal: if a promoted topic becomes outdated or inaccurate and the maintainer does not update, requesting withdrawal is appropriate.
-
Does a peptide degrade silently, with no visual change? Replied, post #74 · Practice › Storage & stability · 19 Jul 2026 · 0 likes Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later need to know whether it has been sitting for weeks or days, the…
-
Request: a per-category review queue Replied, post #111 · Meta › Feature requests · 18 Jul 2026 · 4 likes I read post #109 twice before replying, because I had assumed the opposite. Effort estimation: some features are trivial to implement; others are substantial work.…
-
Fasting versus non-fasting and which tests care Replied, post #70 · Clinical › Bloodwork · 15 Jul 2026 · 33 likes post #69 answers the question as asked. The question underneath it is different. HbA1c and glucose: HbA1c reflects average glucose over months; a spot glucose…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #35 · Clinical › Prescriber conversations · 14 Jul 2026 · 13 likes This follows post #32 rather than contradicting it. What to bring: copies of relevant lab results, pharmacy records (to confirm doses actually taken), and records of…
-
Journal club: semaglutide in MASH, and surrogate endpoints Replied, post #27 · Evidence › Journal club · 14 Jul 2026 · 2 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
Seven-day rolling means and why weekly readings mislead Replied, post #22 · Outcomes › Progress reports · 13 Jul 2026 · 1 like For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Seven-day rolling means and why weekly readings mislead Replied, post #13 · Outcomes › Progress reports · 11 Jul 2026 · 4 likes Measurement noise: day-to-day body mass varies by more than a kilogram on hydration, glycogen, and gut contents alone. A weekly reading is a single noisy sample of a…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #75 · Start Here › Welcome · 11 Jul 2026 · 0 likes On post #71 — agreed on the reasoning, with one qualification. Nothing here requires expertise. The experienced members here got that way by posting questions, not by…
-
CJC-1295 with and without DAC: what the modification does Replied, post #107 · Compounds › Secretagogues & GH axis · 9 Jul 2026 · 10 likes On post #103 — agreed on the reasoning, with one qualification. IGF-1 as a surrogate: it is a better integrated measure than a spot growth hormone level and it is still…
-
Common supplements people ask about, assessed one at a time Replied, post #16 · Practice › Interactions · 6 Jul 2026 · 16 likes Coming back to post #14, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
What to include when your question involves a chromatogram — one year on Replied, post #65 · Start Here › How to Ask · 6 Jul 2026 · 28 likes post #64 is right about the mechanism and I think understates the practical bit. Context that matters: compound, how long in, current dose, relevant history. Context…
-
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #36 · Documentation › Doc review · 5 Jul 2026 · 1 like post #35 is right about the mechanism and I think understates the practical bit. Review date disputes: if a maintained page's review date is approaching and it has not…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #75 · Wellbeing › Sleep · 3 Jul 2026 · 0 likes Sleep apnoea improvement: as weight is lost, sleep apnoea usually improves. The timeframe is weeks to months, not immediate. Improvement often is gradual rather than…
-
Blinding yourself: practical methods and their limits Replied, post #38 · Research Methods › N-of-1 designs · 29 Jun 2026 · 18 likes Generalisability: a robust n-of-1 result applies to you. It does not tell you much about whether the effect generalises to others similar to you, much less to people…
-
What to include when your question involves a chromatogram — one year on Replied, post #54 · Start Here › How to Ask · 28 Jun 2026 · 0 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
-
About the Welcome category Replied, post #5 · Start Here › Welcome · 26 Jun 2026 · 7 likes Your introduction is well framed. You have given enough context that people can actually answer. That is rarer than it sounds and it matters more than it sounds.
-
Composite endpoints and the component doing the work Replied, post #4 · Evidence › Trials · 23 Jun 2026 · 29 likes Picking up the opening post: that is the part I would want checked first. Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #119 · Clinical › Bloodwork · 22 Jun 2026 · 3 likes HbA1c and glucose: HbA1c reflects average glucose over months; a spot glucose measurement reflects the moment. Trending glucose downward while HbA1c stays flat is a…
-
Semaglutide and alcohol: what is actually documented Replied, post #11 · Compounds › Semaglutide · 22 Jun 2026 · 0 likes Coming back to post #9, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #55 · Practice › Administration · 14 Jun 2026 · 6 likes I read post #53 twice before replying, because I had assumed the opposite. Cold solution and stinging: warming the vial in your hands for a minute before injection…
-
Micronutrient adequacy at low total intake Replied, post #90 · Nutrition & Training › Protein & intake · 14 Jun 2026 · 0 likes Eating anything at all: on substantial appetite suppression, eating enough total calories to maintain lean mass is the priority. Protein comes second to total intake.
-
Revisiting: Spike-and-recover accuracy for a peptide assay Replied, post #2 · Analytics › Method validation · 11 Jun 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #56 · Outcomes › Progress reports · 7 Jun 2026 · 6 likes Coming back to post #54, because the follow-up matters more than the original answer. Longitudinal report with the method stated: same scale, same time of day, same…
-
A critique that turned out to be unfair, retracted by its author Replied, post #8 · Evidence › Study critique · 6 Jun 2026 · 4 likes I read post #6 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #66 · Compounds › Repair & healing peptides · 4 Jun 2026 · 22 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Reading a home test result without over-claiming Replied, post #60 · Analytics › Home & field testing · 30 May 2026 · 1 like Coming back to post #58, because the follow-up matters more than the original answer. Why third-party testing is stronger: a home test run by the person who made the…
-
Why the timeline is on the right and not the left — what changed since Replied, post #42 · Meta › Site feedback · 24 May 2026 · 26 likes Moderation decisions: if you disagree with a moderation decision, raising it here gives it visibility. Staff will reconsider if you make a substantive case.
-
How shortages have affected compounding permissions — does this still hold? Replied, post #3 · Access › Shortages · 16 May 2026 · 25 likes Resuming after a gap: after a gap of days or a few weeks, most people resume at the dose they were on when they stopped. Gaps of months might require retitration…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #45 · Sourcing › Red flags · 12 May 2026 · 18 likes Worth separating two things that post #41 runs together. Unresponsiveness: a supplier that does not reply to reasonable requests for documentation or clarification is…
-
Cold solution and stinging: the simplest fix Replied, post #23 · Practice › Administration · 8 May 2026 · 0 likes A genuinely late dose: the labelling generally says that if the next dose is more than a couple of days away, take it as soon as you notice. If the next dose is close,…
-
Does a peptide degrade silently, with no visual change? Replied, post #23 · Practice › Storage & stability · 8 May 2026 · 19 likes Container choice matters: the material of the vial, the rubber closure, the fill volume all affect how quickly the contents degrade. Smaller fill volumes lose less to…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #61 · Sourcing › Logistics · 5 May 2026 · 19 likes Worth separating two things that post #57 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #52 · Practice › Administration · 24 Apr 2026 · 4 likes Coming back to post #50, because the follow-up matters more than the original answer. Bleeding at the injection site: normal and usually minimal. A little blood at the…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #87 · Practice › Reconstitution · 23 Apr 2026 · 2 likes On post #83 — agreed on the reasoning, with one qualification. A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL…
-
Light exposure: how much protection is proportionate? Replied, post #3 · Practice › Storage & stability · 21 Apr 2026 · 0 likes Worth separating two things that the opening post runs together. Beyond-use dating: the date after which a prepared solution should not be used. It is an estimate based…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #14 · Safety › Contraindications · 19 Apr 2026 · 24 likes Gastroparesis or severe delayed gastric emptying: these compounds slow gastric emptying. Pre-existing severe gastroparesis can be worsened. That is a relative…
-
About the COA interpretation category Replied, post #8 · Analytics › COA interpretation · 9 Apr 2026 · 0 likes Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from reversed-phase purification or acetate after salt exchange. The…
-
The headache that turns out to be dehydration — the long version Replied, post #19 · Nutrition & Training › Hydration & electrolytes · 8 Apr 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #74 · Compounds › Tirzepatide · 8 Apr 2026 · 2 likes Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…
-
Why this subcategory is stricter about sourcing than most Replied, post #14 · Compounds › Secretagogues & GH axis · 2 Apr 2026 · 7 likes This follows post #11 rather than contradicting it. Evidence quality in the secretagogue literature is honestly weaker than in the incretin literature. Large randomised…
-
Revisiting: Absolute versus relative contraindications Replied, post #56 · Safety › Contraindications · 1 Apr 2026 · 19 likes Disordered eating history: appetite suppression can trigger relapse in people with history of anorexia, bulimia, or other eating disorders. This is a relative…
-
Five questions in one post gets you one answer — how to split them Replied, post #39 · Start Here › How to Ask · 25 Mar 2026 · 24 likes Arithmetic questions: write out the steps. "I have a 10 mg vial, I added 2 mL, I want a 0.25 mg dose, and I get this number for the syringe mark" is answerable. "How…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #43 · Outcomes › Body composition · 17 Mar 2026 · 0 likes post #42 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Revisiting: Maintainer handover: how it works Replied, post #48 · Meta › Wiki maintenance · 12 Mar 2026 · 3 likes Cross-referencing: if two pages should reference each other but do not, suggesting the cross-reference helps the maintainer see the connection.
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #8 · Lounge › Introductions · 7 Mar 2026 · 0 likes Coming back to post #6, because the follow-up matters more than the original answer. Say hello. No question required. Introduce yourself if you want to give context for…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #61 · Pharmacology › Pharmacokinetics · 5 Mar 2026 · 19 likes Renal clearance: these compounds are cleared partly via the kidney. In severe renal impairment, clearance is slowed and accumulation risk is higher. Dose adjustments…
-
Contributing data without breaching anyone's privacy Replied, post #38 · Data & Tools › Datasets · 4 Mar 2026 · 22 likes Community-collected datasets: some members have compiled datasets from their own experience and shared them. They are self-reported, unblinded, and therefore limited as…
-
Measurement error in a self-reported exposure Replied, post #125 · Evidence › Study critique · 28 Feb 2026 · 0 likes Bias towards the null and bias away from the null: different criticisms have different directions. Differential dropout might bias away from null; conservative…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #83 · Clinical › Bloodwork · 22 Feb 2026 · 19 likes post #82 answers the question as asked. The question underneath it is different. Biological variation: the person-to-person variation in a biomarker for a healthy…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #78 · Meta › Site feedback · 21 Feb 2026 · 33 likes Navigation problems: if you cannot find something you expected to exist, or the path to it is unclear, report it. Site architecture affects usability.
-
Second pass at: What pooling buys you and what it destroys Replied, post #20 · Evidence › Meta-analyses · 21 Feb 2026 · 18 likes Number needed to treat from a meta-analysis: can be computed from the pooled estimate if the baseline risk is specified. More interpretable than pooled relative effects.
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #105 · Practice › Dosing & titration · 20 Feb 2026 · 16 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #3 · Pharmacology › Formulation chemistry · 14 Feb 2026 · 12 likes Antioxidants: compounds that prevent oxidation (which damages peptides) are sometimes included. Methionine oxidation is a common degradation pathway and antioxidants…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #65 · Analytics › Mass spectrometry · 14 Feb 2026 · 1 like Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass is predictable from the base mass.
-
[2026 update] Currency conversion and the cost you did not see Replied, post #9 · Sourcing › Payments · 14 Feb 2026 · 21 likes Bank transfer and finality: once a bank transfer is sent, it is final. The money is gone. There is no recourse with the bank if the supplier disappears. That is why…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #20 · Practice › Interactions · 12 Feb 2026 · 3 likes Picking up post #17: that is the part I would want checked first. Supplements and herbs: many have no established interaction. Some do. If you are taking something…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #21 · Analytics › Mass spectrometry · 12 Feb 2026 · 0 likes Worth separating two things that post #17 runs together. Desalting before analysis: some samples need desalting to remove salts that suppress the peptide signal. Report…
-
Solubility limits and what a cloudy solution is telling you Replied, post #3 · Pharmacology › Formulation chemistry · 10 Feb 2026 · 8 likes On the opening post — agreed on the reasoning, with one qualification. Amino acid residues and formulation: the specific sequence and composition of a peptide affects…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #48 · Clinical › Bloodwork · 9 Feb 2026 · 0 likes Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things. Bilirubin helps narrow down the cause. Multiple markers together are more…
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #18 · Practice › Storage & stability · 29 Jan 2026 · 17 likes post #17 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #91 · Compounds › Oral incretins · 25 Jan 2026 · 17 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #29 · Clinical › Special populations · 22 Jan 2026 · 0 likes Worth separating two things that post #25 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Tag proliferation and whether we should prune — what changed since Replied, post #4 · Meta › Site feedback · 19 Jan 2026 · 3 likes Community norms: if you think a norm has drifted or is not being followed consistently, raising it here can prompt discussion and realignment.
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #63 · Pharmacology › Receptor biology · 17 Jan 2026 · 0 likes Central versus peripheral action: GLP-1 agonism works through both central nervous system effects (appetite) and peripheral effects (gastric motility, insulin). The…
-
Managing an unplanned gap in supply Replied, post #5 · Access › Shortages · 13 Jan 2026 · 28 likes Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply returns is different from gradually tapering. The two are…
-
[2026 update] Reading a supplementary appendix and finding the interesting part Replied, post #8 · Evidence › Trials · 10 Jan 2026 · 3 likes On post #4 — agreed on the reasoning, with one qualification. Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical…
-
A partial dose because the pen emptied mid-injection Replied, post #45 · Practice › Administration · 8 Jan 2026 · 6 likes A genuinely late dose: the labelling generally says that if the next dose is more than a couple of days away, take it as soon as you notice. If the next dose is close,…
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #17 · Data & Tools › Calculators · 7 Jan 2026 · 3 likes I read post #15 twice before replying, because I had assumed the opposite. Dose equivalence calculator: compounds have different potencies. The calculator is provided…
-
MHRA statements, read directly Replied, post #58 · Regional › UK & Ireland · 30 Dec 2025 · 8 likes Coming back to post #56, because the follow-up matters more than the original answer. Regional variation in NHS: access varies dramatically by region depending on local…
-
Aggregates and why a purity assay may miss them entirely Replied, post #27 · Analytics › Impurities & related substances · 25 Dec 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Comparing two chromatograms from different laboratories, properly Replied, post #41 · Analytics › HPLC & UHPLC · 14 Dec 2025 · 1 like Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and eluted by increasing organic solvent. For peptides the mobile…
-
Aggregates and why a purity assay may miss them entirely Replied, post #4 · Analytics › Impurities & related substances · 11 Dec 2025 · 2 likes Picking up post #2: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Prescription requirements and telehealth models Replied, post #33 · Sourcing › Regulatory · 26 Nov 2025 · 24 likes Primary documents matter: regulatory positions are published in official documents. Reading the regulatory agency's website directly is more reliable than reading a…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #22 · Access › Pricing · 23 Nov 2025 · 2 likes Price variation between pharmacies: identical prescriptions can cost different amounts at different pharmacies because pharmacies negotiate individually with insurers…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #113 · Start Here › How to Ask · 18 Nov 2025 · 0 likes On post #109 — agreed on the reasoning, with one qualification. Arithmetic questions: write out the steps. "I have a 10 mg vial, I added 2 mL, I want a 0.25 mg dose,…
-
[2026 update] What steady state means for the decision to escalate Replied, post #119 · Practice › Dosing & titration · 17 Nov 2025 · 19 likes Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
-
Pen dose counters: what a click does and does not guarantee Replied, post #64 · Devices › Pens & autoinjectors · 16 Nov 2025 · 24 likes I read post #62 twice before replying, because I had assumed the opposite. Storage after first use: most pens can be stored at room temperature after first use, even if…
-
Realistic expectations for strength while losing weight quickly Replied, post #36 · Nutrition & Training › Resistance training · 14 Nov 2025 · 1 like Adaptation and plateau: if strength does not change for weeks, that is stability, not backsliding. Expecting continuous progress during weight loss is unrealistic.
-
Documentation that appears only after payment Replied, post #75 · Sourcing › Red flags · 13 Nov 2025 · 2 likes Anonymity: a supplier that will not disclose legal name, address, or responsible person is not operating in a way that allows accountability.
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #81 · Practice › Reconstitution · 18 Oct 2025 · 7 likes Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic solutions (close to blood osmolarity) are less…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #67 · Compounds › Semaglutide · 30 Sep 2025 · 18 likes Picking up post #64: that is the part I would want checked first. The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear.…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #105 · Practice › Side effects · 30 Sep 2025 · 16 likes Picking up post #102: that is the part I would want checked first. Injection site reaction: local erythema, nodules, or induration at injection sites is reported by…
-
Titles that describe the question, not the situation Replied, post #107 · Start Here › How to Ask · 27 Sep 2025 · 14 likes Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it refers to. Pick the specific part and ask that specific question…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #109 · Compounds › Retatrutide · 10 Sep 2025 · 1 like On post #105 — agreed on the reasoning, with one qualification. Mass and identity: a report on retatrutide should state the mass detected by LC-MS, not assume a…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #13 · Compounds › Semaglutide · 5 Sep 2025 · 1 like post #12 answers the question as asked. The question underneath it is different. The opalescent appearance in semaglutide solutions is occasionally noted and the…
-
[2026 update] A single out-of-range value on an otherwise normal panel Replied, post #8 · Clinical › Bloodwork · 2 Sep 2025 · 0 likes Worth separating two things that post #4 runs together. TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free hormone…
-
Insomnia at a dose step: reported experiences Replied, post #8 · Wellbeing › Sleep · 1 Sep 2025 · 0 likes Sleep apnoea improvement: as weight is lost, sleep apnoea usually improves. The timeframe is weeks to months, not immediate. Improvement often is gradual rather than…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #63 · Evidence › Journal club · 19 Aug 2025 · 0 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Coming back to: Official shortage notices and what they authorise Replied, post #92 · Access › Shortages · 16 Aug 2025 · 32 likes On post #88 — agreed on the reasoning, with one qualification. Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct…
-
A request that was declined, and the reasoning — a second dataset Replied, post #53 · Documentation › Wiki requests · 11 Aug 2025 · 6 likes Cross-referencing: if you notice two pages that should reference each other but do not, suggest the cross-reference.
-
"Should I double up?" — answered once, at length, calmly Replied, post #11 · Practice › Administration · 10 Aug 2025 · 1 like This follows post #8 rather than contradicting it. Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one…
-
Coming back to: When "no data" is the complete and final answer Replied, post #40 · Compounds › Other compounds · 10 Jul 2025 · 29 likes Coming back to post #38, because the follow-up matters more than the original answer. Melanocortin agonists: mechanism involves the melanocortin-4 receptor pathway that…
-
[2026 update] Dose numbers across compounds are not on the same scale Replied, post #19 · Practice › Dosing & titration · 24 Jun 2025 · 14 likes On post #15 — agreed on the reasoning, with one qualification. Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long…
-
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #67 · Devices › Pens & autoinjectors · 15 Jun 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
High-resolution MS on aggregates and what it can see Replied, post #6 · Analytics › Mass spectrometry · 14 Jun 2025 · 8 likes On post #2 — agreed on the reasoning, with one qualification. Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #121 · Devices › Cold chain · 12 Jun 2025 · 0 likes Temperature excursions: brief excursions above 8 °C are tolerable for most compounds. Hours to a day at room temperature is usually acceptable. Days to weeks at room…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #26 · Access › Insurance & coverage · 8 Jun 2025 · 0 likes I read post #24 twice before replying, because I had assumed the opposite. Coverage for weight management versus diabetes: many formularies cover these compounds for…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #84 · Practice › Reconstitution · 4 Jun 2025 · 4 likes I read post #82 twice before replying, because I had assumed the opposite. Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands…
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #49 · Clinical › Comorbidities · 26 May 2025 · 0 likes Cardiovascular disease: several compounds have cardiovascular outcome trials. SELECT was in people without diabetes; SUSTAIN 6 was in high-risk diabetes. Absolute…
-
Pregnancy as an absolute contraindication Replied, post #14 · Safety › Contraindications · 17 May 2025 · 7 likes Disordered eating history: appetite suppression can trigger relapse in people with history of anorexia, bulimia, or other eating disorders. This is a relative…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #20 · Outcomes › Body composition · 9 May 2025 · 0 likes Precision versus accuracy: the precision you need depends on what question you are answering. "Am I losing fat?" requires less precision than "Is my lean mass…
-
Lean mass preservation: what the evidence supports Replied, post #2 · Outcomes › Body composition · 3 May 2025 · 17 likes the opening post is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather…
-
A claim built entirely on a subgroup analysis Replied, post #11 · Evidence › Study critique · 29 Apr 2025 · 12 likes post #10 answers the question as asked. The question underneath it is different. Choosing the worst interpretation: "The confidence interval includes a harmful effect"…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #95 · Compounds › Semaglutide · 28 Apr 2025 · 13 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #91 · Practice › Reconstitution · 28 Apr 2025 · 4 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
-
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #23 · Devices › Pens & autoinjectors · 21 Apr 2025 · 0 likes Pen confusion between compounds: if you are using multiple pens or alternating pens, confirming you have the correct pen before injection prevents administration…
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #60 · Compounds › Secretagogues & GH axis · 19 Apr 2025 · 19 likes Why this subcategory is stricter about sourcing than most: the evidence base is weaker and that is precisely why documentation quality matters more. A supplier page…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #65 · Access › Pricing · 14 Apr 2025 · 0 likes International pricing: the same compound costs very different amounts in different countries because healthcare systems and regulatory frameworks differ. Generally, US…
-
Coverage for the indication versus for the drug Replied, post #21 · Access › Insurance & coverage · 6 Apr 2025 · 0 likes I read post #19 twice before replying, because I had assumed the opposite. Formulary status: the list of covered medications and the tier (how much you pay) they are…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #90 · Documentation › Doc review · 4 Apr 2025 · 4 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Reading order for a first week here, and what to skip until later Replied, post #49 · Start Here › Welcome · 23 Mar 2025 · 0 likes Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #104 · Sourcing › Vendor reports · 18 Mar 2025 · 0 likes Multiple services on one lot: agreement across two independent laboratories is stronger than a high number from one. Our vendor pages deliberately mix services for that…
-
Albumin binding and how it produces a long half-life Replied, post #14 · Pharmacology › Pharmacokinetics · 14 Mar 2025 · 16 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Reading a chromatogram someone posted without axes Replied, post #9 · Analytics › HPLC & UHPLC · 8 Mar 2025 · 0 likes I read post #7 twice before replying, because I had assumed the opposite. Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #67 · Sourcing › Regulatory · 2 Mar 2025 · 11 likes Preclinical versus clinical: compounds with strong preclinical data can fail in clinical trials. Compounds with no human data are being used on theoretical grounds. The…
-
Revisiting: Aggregate verification data across the directory, with caveats Replied, post #14 · Sourcing › Independent verification · 22 Feb 2025 · 9 likes PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over…
-
Assessing a warm arrival: the decision process Replied, post #5 · Sourcing › Logistics · 21 Feb 2025 · 4 likes post #4 is right about the mechanism and I think understates the practical bit. Documentation after arrival: photograph the parcel and its contents on arrival. If…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #62 · Analytics › Mass spectrometry · 18 Feb 2025 · 10 likes Charge states observed: for semaglutide (4113.6 Da) the doubly charged ion appears at m/z ≈ 2057, triply charged at ≈ 1371, quadruply at ≈ 1029. Those are the positions…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #53 · Analytics › Mass spectrometry · 10 Feb 2025 · 5 likes Desalting before analysis: some samples need desalting to remove salts that suppress the peptide signal. Report whether desalting was used, because it can affect the…
-
Protein density versus volume when you cannot eat much Replied, post #95 · Nutrition & Training › Protein & intake · 9 Feb 2025 · 0 likes Worth separating two things that post #91 runs together. Protein targets during weight loss: the standard recommendation is 1.6 to 2.2 grams per kilogram of body…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #10 · Documentation › Doc review · 3 Feb 2025 · 27 likes Revision disputes: if you disagree with an edit a maintainer made to a page, discuss it here. The goal is accuracy and clarity, not authorship.
-
Distinguishing a deletion sequence by mass alone — the long version Replied, post #2 · Analytics › Mass spectrometry · 25 Jan 2025 · 16 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Reading a supplementary appendix and finding the interesting part Replied, post #73 · Evidence › Trials · 21 Jan 2025 · 2 likes The estimand: what the trial set out to estimate. Two trials can be identical in structure but estimate different things by using different handling rules for people…
-
Recovery when intake is low: what to cut first Replied, post #92 · Nutrition & Training › Resistance training · 15 Jan 2025 · 5 likes Worth separating two things that post #88 runs together. Programming while losing weight quickly: realistic expectations are crucial. Strength often stays surprisingly…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #111 · Analytics › Method validation · 5 Jan 2025 · 0 likes Coming back to post #109, because the follow-up matters more than the original answer. Robustness: the method gives consistent results when minor parameters vary.…
-
What we do not know about retatrutide, listed explicitly Replied, post #43 · Compounds › Retatrutide · 4 Jan 2025 · 2 likes Dose escalation in the published trials: the protocols started at lower doses and escalated by defined steps. The step sizes are documented and they may or may not…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #148 · Compounds › Oral incretins · 29 Dec 2024 · 4 likes Worth separating two things that post #144 runs together. Oral versus injectable exposure: comparing a 14 mg oral dose with a 0.5 mg injectable dose is comparing apples…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #117 · Compounds › Oral incretins · 28 Dec 2024 · 11 likes Trial adherence in an oral trial with strict administration requirements is genuinely worse than trial-published data often suggests. That is why the exposure…
-
Coming back to: Reading a meta-analysis you disagree with, fairly Replied, post #11 · Evidence › Meta-analyses · 27 Dec 2024 · 31 likes Fixed-effects versus random-effects models: fixed-effects assumes all studies are estimating the same thing and variation is sampling error. Random-effects assumes…
-
Oxidation pathways for methionine and tryptophan Replied, post #20 · Analytics › Impurities & related substances · 27 Dec 2024 · 32 likes Off-target structures: if the sequence synthesis goes wrong, a completely different amino acid can be incorporated. The resulting off-target peptide is a structural…
-
Building a sensible monitoring schedule with your prescriber Replied, post #109 · Clinical › Bloodwork · 23 Dec 2024 · 0 likes TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free hormone levels. If TSH is abnormal, free thyroid hormones confirm…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #75 · Practice › Side effects · 15 Dec 2024 · 17 likes Injection site reaction: local erythema, nodules, or induration at injection sites is reported by some people. Site rotation, avoiding reinjection into the same area…
-
TB-500 and thymosin beta-4: the fragment versus the protein — does this still hold? Replied, post #17 · Compounds › Repair & healing peptides · 13 Dec 2024 · 12 likes TB-500 is usually the 7-residue actin-binding fragment of thymosin beta-4, not the full 43-residue protein. The two are routinely conflated in supplier documentation…
-
[2026 update] New subcategory: rationale and scope Replied, post #53 · Meta › Announcements · 9 Dec 2024 · 3 likes Implementation timeline: announcements include when a change takes effect. Marking the date helps you know whether the change is already in effect.
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #70 · Compounds › Tirzepatide · 4 Dec 2024 · 0 likes post #69 is right about the mechanism and I think understates the practical bit. SURMOUNT-OSA is notable because it used an objective physiological endpoint, the…
-
What we do not know about retatrutide, listed explicitly Replied, post #7 · Compounds › Retatrutide · 28 Nov 2024 · 27 likes Worth separating two things that post #3 runs together. TRIUMPH is phase 3 and it is ongoing. No phase 3 results exist. Nothing should be attributed to TRIUMPH because…
-
Taste changes and food aversion, reported and discussed Replied, post #39 · Practice › Side effects · 10 Nov 2024 · 0 likes Timeline matters: onset, duration, pattern over days or weeks, relationship to injection and to meals all provide information that "I have nausea" does not. Posting…
-
Converting between mg/mL and units per dose, both directions Replied, post #80 · Practice › Reconstitution · 7 Nov 2024 · 1 like Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #7 · Wellbeing › Mental health · 10 Oct 2024 · 0 likes post #6 answers the question as asked. The question underneath it is different. Sleep and mental health: these compounds can affect sleep for some people. Sleep…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #79 · Analytics › COA interpretation · 9 Oct 2024 · 4 likes Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide content independent of chromatographic purity. Very…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #38 · Compounds › Other compounds · 8 Oct 2024 · 17 likes This follows post #35 rather than contradicting it. Distinguishing marketed research compounds from true chemical synthesis: some online suppliers sell compounds that…
-
A rising related-substance total over six months: degradation or method drift? Replied, post #16 · Analytics › Impurities & related substances · 29 Aug 2024 · 0 likes Disulfide formation: if a peptide contains cysteine, it can form disulfide bonds with itself or with other molecules. Under oxidising conditions multiple species…
-
Follow-up: What this community means by "a source", in practical terms Replied, post #4 · Start Here › Welcome · 22 Aug 2024 · 20 likes Introducing yourself is fine and requires no question. Post in this subcategory, describe the context that matters for why you are here, and lurk for a bit before…
-
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #6 · Practice › Side effects · 2 Aug 2024 · 0 likes Vomiting: when it is expected (first-dose reactions or early titration) and when it is a reason to stop and seek help are different. Occasional vomiting during…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #3 · Nutrition & Training › Hydration & electrolytes · 16 Jul 2024 · 1 like Fluid intake: baseline needs increase with gastrointestinal effects and exercise. Thirst is not a reliable guide during appetite suppression. Drinking regularly (not…
-
Where the four-week escalation interval comes from, and what it is not Replied, post #26 · Practice › Dosing & titration · 20 Jun 2024 · 17 likes Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
-
Spreadsheets: an appreciation Replied, post #18 · Lounge › Off topic · 8 Jun 2024 · 0 likes This follows post #15 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…